Vous voyez ces citations basées sur la navigation précédente liée à des secteurs tels que
Prénom | P / E | PEG | Rendement du dividende | La marge d'exploitation | ROCE | Le rendement des actifs |
---|---|---|---|---|---|---|
4basebio | - 22.9 | 0.0 | 0.00% | -2,179.10% | -0.70% | -0.44% |
Pharmacie 4D | 0.0 | 0.0 | 0.00% | -13,502.49% | -2.92% | -1.26% |
Abcam | 0.0 | 0.0 | 0.00% | 5.27% | 0.07% | 0.02% |
Abzène | 0.0 | 0.0 | 0.00% | -68.06% | -0.65% | -0.26% |
Agronomie limitée | 3.9 | 0.0 | 0.00% | n / a | 0.13% | 0.13% |
Thérapeutique contre les allergies | - 0.4 | 0.0 | 0.00% | -59.27% | -1.30% | -0.75% |
Alliance Pharma | 9.3 | - 0.3 | 4.47% | 6.31% | 0.16% | 0.00% |
Groupe de soins aux animaux | n / a | n / a | n / a | n / a | n / a | n / a |
Anpario | 15.0 | - 1.1 | 4.65% | 8.14% | 0.11% | 0.06% |
Groupe Aptamer | - 0.1 | 0.0 | 0.00% | -465.58% | -6.27% | -2.85% |
Aqua Bounty Technologies Inc. (Reg S) | 0.0 | 0.0 | 0.00% | n / a | -1.28% | -1.08% |
Arecor Thérapeutique | - 4.4 | 0.0 | 0.00% | -442.36% | -0.72% | -0.43% |
AstraZeneca | 35.1 | 0.4 | 2.15% | 17.88% | 0.60% | 0.06% |
Groupe Avacta | - 3.2 | 0.0 | 0.00% | -326.25% | -0.72% | -0.42% |
Titres de référence | - 18.4 | 0.0 | 0.00% | -3.14% | -0.03% | -0.05% |
Beximco Pharmaceuticals Ltd. RDA (Reg S) | 1,069.1 | 48.8 | 0.02% | 21.99% | 0.11% | 0.06% |
Produits pharmaceutiques Biodexa | n / a | n / a | n / a | n / a | n / a | n / a |
Biofrontera SA (DI) | 0.0 | 0.0 | 0.00% | -279.67% | -1.02% | -0.77% |
Bioventix | 27.7 | 3.1 | 3.42% | 78.28% | 0.83% | 0.63% |
BiVictriX Thérapeutique | - 3.0 | 0.0 | 0.00% | n / a | -0.73% | -0.55% |
BTG | 0.0 | 0.0 | 0.00% | 14.00% | 0.23% | 0.07% |
Fonds de découverte C4X | - 2.2 | 0.0 | 0.00% | -784.44% | -2.35% | -1.26% |
n / a | n / a | n / a | n / a | n / a | n / a | |
Groupe de marques de froid | - 1.4 | 0.0 | 0.00% | -496.82% | -0.90% | -0.70% |
Cizzle Biotechnologie Holdings | - 6.2 | 0.0 | 0.00% | n / a | n / a | -0.33% |
Cyprotex | 0.0 | 0.0 | 0.00% | 12.68% | 0.15% | -0.42% |
Produits pharmaceutiques Dechra | - 157.2 | 0.0 | 0.32% | 0.83% | 0.01% | -0.02% |
Deep Verge Plc | 0.1 | 0.0 | 0.00% | -36.34% | -0.32% | -0.09% |
Destin Pharma | - 2.7 | 0.0 | 0.00% | n / a | -1.45% | -0.74% |
Groupe diurne | 0.0 | 0.0 | 0.00% | -404.68% | -0.89% | -0.62% |
e-Thérapeutique | - 7.1 | 0.0 | 0.00% | -2,155.58% | -0.31% | -0.24% |
EastPharma Ltd RDA (Reg S) | 0.0 | 0.0 | 0.00% | 12.96% | 0.09% | 0.02% |
Groupe ECO Santé Animale | 57.4 | 0.0 | 0.00% | 5.27% | 0.08% | 0.01% |
Recherche Éden | n / a | n / a | n / a | n / a | n / a | n / a |
Ergomé | 31.6 | 8.7 | 0.00% | 12.99% | 0.55% | 0.12% |
Evgen Pharma | - 0.6 | 0.0 | 0.00% | -1,154.75% | -0.96% | -0.65% |
Faron Pharmaceuticals Oy (DI) | - 3.3 | 0.0 | 0.00% | n / a | 9.10% | -3.03% |
Futura Médical | - 20.0 | 0.0 | 0.00% | n / a | n / a | -0.90% |
Genflow Biosciences | - 3.2 | 0.0 | 0.00% | n / a | -0.56% | -0.51% |
Genre | 20.8 | 8.2 | 1.81% | 5.87% | 0.08% | 0.03% |
GSK | 11.0 | 1.0 | 2.46% | 22.24% | 0.67% | 0.08% |
Gunsynd | - 0.4 | 0.0 | 0.00% | 158.53% | -0.80% | -0.76% |
GW Pharmaceuticals | 0.0 | 0.0 | 0.00% | -200.53% | -0.24% | -0.15% |
Haléon | 19.3 | - 3.2 | 1.80% | 17.66% | 0.70% | 0.03% |
Hemogenyx Pharma | - 3.5 | 0.0 | 0.00% | n / a | -0.64% | -0.56% |
Hikma Pharmaceuticals | 10.9 | 0.5 | 2.97% | 12.77% | 0.16% | 0.04% |
Groupe Horizon Discovery | 0.0 | 0.0 | 0.00% | -17.27% | -0.21% | -0.03% |
HUTCHMED (Chine) Limited | 28.1 | 0.0 | 0.00% | 2.19% | 0.03% | 0.08% |
Hvivo | 0.0 | 0.0 | 0.00% | -164.40% | -1.23% | -0.60% |
Immupharma | - 1.7 | 0.0 | 0.00% | n / a | -1.48% | -0.96% |
Indivior | 2,138.7 | 0.0 | 0.00% | -0.37% | -0.07% | 0.00% |
Capital inspiré | 0.0 | 0.0 | 0.00% | -0.82% | 0.00% | 0.00% |
Mexico | - 3.3 | 0.0 | 0.00% | -21.56% | -0.25% | -0.09% |
LungLife AI, Inc (DI) | - 1.3 | 0.0 | 0.00% | -32,250.00% | -0.96% | -0.51% |
Maxcyte Inc (DI/REG S) | n / a | n / a | n / a | -116.98% | -0.19% | -0.14% |
Groupe Mereo Biopharma | 0.0 | 0.0 | 0.00% | n / a | -1.28% | -0.40% |
MGC Pharmaceuticals Limited VAN (DI) | 0.0 | 0.0 | 0.00% | -622.88% | n / a | -2.11% |
Motif Biologique | 0.0 | 0.0 | 0.00% | n / a | -1.59% | -1.23% |
N4 Pharma | - 1.2 | 0.0 | 0.00% | n / a | -0.57% | -0.48% |
Nuformix | - 2.4 | 0.0 | 0.00% | n / a | n / a | -0.19% |
Okyo Pharma Limited VAN | 0.0 | 0.0 | 0.00% | n / a | n / a | -1.21% |
Ondine Biomedical Inc. VAN (CDI) | - 1.6 | 0.0 | 0.00% | -2,940.91% | -1.53% | -1.17% |
OptiBiotix Santé | 6.7 | - 0.1 | 0.00% | -544.64% | n / a | 0.22% |
Ovoca Bio (CDI) | - 0.1 | 0.0 | 0.00% | n / a | -1.74% | -0.60% |
Oxford Biomédica | - 4.9 | 0.0 | 0.00% | -21.59% | -0.12% | -0.09% |
Holdings d'Oxford Cannabinoid Technologies | - 0.7 | 0.0 | 0.00% | n / a | -1.80% | -1.32% |
Technologies d'Oxford Nanopore | - 6.4 | 0.0 | 0.00% | -99.38% | -0.25% | -0.20% |
Pfizer Inc. | n / a | n / a | n / a | 1.81% | n / a | n / a |
OJSC Pharmstandard GDR (Reg S) | n / a | n / a | n / a | n / a | n / a | n / a |
Pléthore Solutions Holdings | 0.0 | 0.0 | 0.00% | -419.63% | -3.55% | -2.76% |
Pharmabeg | - 10.5 | 0.0 | 0.00% | n / a | -0.31% | -0.24% |
Sciences du protéome | 7.5 | 0.0 | 0.00% | 22.21% | 0.24% | 0.11% |
PureTech Santé | - 15.6 | 0.0 | 0.00% | -1,266.53% | -0.38% | -0.07% |
Pharma quantique | 0.0 | 0.0 | 0.00% | -11.10% | -1.17% | -0.25% |
Redx Pharma | - 1.9 | 0.0 | 0.00% | -804.85% | -1.56% | -1.29% |
Groupe ReNeuron | - 0.4 | 0.0 | 0.00% | -1,342.45% | -1.34% | -0.56% |
Sareum Holdings | - 2.3 | 0.0 | 0.00% | n / a | -3.53% | -1.58% |
Fonds Scancell | - 6.8 | 0.0 | 0.00% | -226.14% | -1.21% | -0.39% |
Thérapeutique du Bouclier | - 0.1 | 0.0 | 0.00% | -904.72% | 55.74% | -1.83% |
Shire Plc | 0.0 | 0.0 | 0.00% | 16.19% | 0.32% | 0.06% |
Thérapeutique du silence | 0.0 | 0.0 | 0.00% | -654.20% | -28.50% | -0.38% |
Pharmacie Sinclair | 0.0 | 0.0 | 0.00% | -4.77% | 0.11% | 0.00% |
PeauBioThérapeutique | - 7.4 | 0.0 | 0.00% | -2,271.26% | -1.57% | -1.09% |
Skyepharma | 0.0 | 0.0 | 0.00% | 32.85% | 0.59% | 0.25% |
Source BioSciences | 0.0 | 0.0 | 0.00% | 8.94% | 0.17% | 0.03% |
Sommet Thérapeutique | 0.0 | 0.0 | 0.00% | 6.21% | 0.08% | 0.13% |
Synairgène | - 0.6 | 0.0 | 0.00% | n / a | -1.00% | -0.75% |
Taïwan | 0.0 | 0.0 | 0.00% | -88.11% | n / a | -0.22% |
Sciences de la vie de Tiziana | 0.0 | 0.0 | 0.00% | n / a | -0.47% | -0.39% |
Valirx | - 1.2 | 0.0 | 0.00% | n / a | -1.91% | -0.60% |
Groupe Vectura | 0.0 | 0.0 | 0.00% | 69.67% | 0.47% | 0.18% |
Verici DX | - 1.7 | 0.0 | 0.00% | n / a | -1.18% | -0.80% |
Vernalis SA | 0.0 | 0.0 | 0.00% | -127.03% | -0.43% | -0.23% |
Vérone Pharma | 0.0 | 0.0 | 0.00% | n / a | -1.30% | -0.71% |
Verseon Corporation (DI/REG S) | 0.0 | 0.0 | 0.00% | n / a | -0.42% | -0.38% |
Verseon Corporation (Reg S Cat 3) | 0.0 | 0.0 | 0.00% | n / a | -0.42% | -0.38% |
Santé de Yourgene | - 1.7 | 0.0 | 0.00% | -6.76% | -0.08% | -0.03% |